BD (NYSE:BDX) announced today that it expanded customer availability for its all-in-one pre-filled flush syringe. Franklin Lakes, New Jersey-based BD designed its PosiFlush SafeScrub syringe with an integrated disinfection unit. It reinforces compliance to infection prevention guidelines, simplifying nursing workflow. BD built the active disinfection unit right into the tip cap of the PosiFlush SafeScrub […]
BD
FDA clears AI software for MRSA diagnostics from BD
BD (NYSE:BDX) announced today that it received FDA 510(k) clearance for its new Kiestra imaging application that uses AI. The Kiestra methicillin-resistant staphylococcus aureus (MRSA) imaging application uses AI to interpret bacterial growth and release negative specimens with minimal human interaction. Franklin Lakes, New Jersey-based BD designed the Kiestra MRSA application to utilize AI to […]
BD CEO Tom Polen discusses character revealed by COVID-19 crisis
“We couldn’t be more proud of how the team really showed our values,” BD CEO Tom Polen said during a keynote at DeviceTalks Boston. Tom Polen’s original “master plan” included medical school. While preparing for the MCAT out of undergrad, he instead joined a small startup based in California. The startup grew and BD (NYSE:BDX) […]
BD reports strong Q2, raises back end of 2023 guidance
BD shares dipped today despite second-quarter financial results that came in ahead of the consensus forecast. Shares of BDX slid 3.3% at $255 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell 0.5%. The Franklin Lakes, New Jersey–based company posted profits of […]
Is medtech the answer to healthcare challenges?
The aftermath of the COVID-19 pandemic has healthcare in the U.S. and elsewhere facing a host of challenges, but medtech could be part of the answer. Join industry leaders at DeviceTalks Boston, May 10–11, 2023, to find out more about the opportunities. (Register here!) Here are some of the topics to explore at the event: […]
BD unveils ultrasound tech for IV insertions
BD announced today that it launched a new ultrasound device to help clinicians achieve optimal IV placement. The new, easy-to-use, advanced ultrasound device — called the Prevue II — features a special probe. BD designed the Prevue II to address an unmet need in IV access through real-time needle depth markers. Franklin Lakes, New Jersey–based […]
BD names Michelle Quinn as EVP, general counsel
BD announced that it named Michelle Quinn as EVP and general counsel. Franklin Lakes, New Jersey-based BD made Quinn’s appointment effective on April 1. Her responsibilities cover leading the law group at BD. She continues to report to Tom Polen, the company’s chair, CEO and president. Quinn came to BD in 2019. In January of […]
BD wins FDA clearance for high-throughput infectious vaginitis diagnostic
BD (NYSE:BDX) announced today that it received FDA 510(k) clearance for its Vaginal Panel diagnostic on the COR system. The comprehensive diagnostic test directly detects the three most common infectious causes of vaginitis. It uses the BD COR, the company’s high-throughput molecular diagnostic platform for large laboratories. Franklin Lakes, New Jersey-based BD originally received marketing […]
How the BD diagnostics business is driving greater access to care
It’s been a busy time for BD, with recent approvals further driving the company’s diagnostics business forward. Dave Hickey and BD (NYSE:BDX) have their sights on what they call “transformative forces.” These forces could change the delivery of healthcare going forward. Hickey, EVP and president of the Life Sciences segment at BD, said these forces […]
FDA approves BD HPV assay for use with Hologic ThinPrep Pap test
BD (NYSE:BDX) announced today that it received FDA approval for its Onclarity HPV assay for use with the ThinPrep Pap test. The ThinPrep Pap test, developed by Hologic (Nasaq:HOLX), offers Pap and HPV testing from one vial. It accompanies the BD SurePath liquid-based Pap test vial as the most commonly used vials by labs in […]
BD issues vulnerability warning for Alaris infusion monitoring software
BD (NYSE:BDX) today issued a voluntary notification regarding cybersecurity vulnerabilities with its Alaris Infusion Central software. Alaris Infusion Central, a standalone software — separate from pumps — provides data from the Alaris pumps. It allows healthcare providers to monitor infusion data sent from Alaris Plus and Alaris neXus pumps on a computer. Alaris Infusion Central […]